CytomX Therapeutics Inc (NASDAQ:CTMX)

5.15
Delayed Data
As of Oct 15
 -0.04 / -0.77%
Today’s Change
4.28
Today|||52-Week Range
10.05
-21.37%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for CytomX Therapeutics Inc have a median target of 13.00, with a high estimate of 18.00 and a low estimate of 7.00. The median estimate represents a +152.43% increase from the last price of 5.15.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in CytomX Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

Chart unavailable

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.31
Sales
$18.4M
Reporting Date
Nov 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Chart unavailable
Growthquarterly --
[object Object]
Chart unavailable
Growthannually --
[object Object]

Sales

Chart unavailable
Growthquarterly --
[object Object]
Chart unavailable
Growthannually --
[object Object]
Key to the earnings and sales forecast charts.